Antibiotic Injection Recalled for Failed Stability Specification
Eugia US LLC is recalling 1,160 vials of Tobramycin for Injection due to failed water determination testing. Affected lot numbers are 3TB23001 and 3TB23002, expiring 04/30/2025.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable medication due to failed stability specification. No illnesses or injuries have been reported. Per the severity rubric, this qualifies as High (3) because it is a risk-of-harm product (injectable drug with stability concerns) where injury has not yet been reported.
Plain-English summary
Eugia US LLC is recalling 1,160 vials of Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package. The recall was initiated due to a failed stability specification—water determination was found not complying with specification requirements. Lot numbers 3TB23001 and 3TB23002, with an expiration date of 04/30/2025, are affected. The product was distributed nationwide.
Tobramycin is an antibiotic supplied for intravenous use in pharmacy bulk packages. The vials are not for direct infusion. Healthcare providers, pharmacists, and medical facilities should quarantine any remaining stock of the affected lot numbers to prevent further distribution.
Patients who have received Tobramycin from the affected lots should not discontinue treatment without consulting their healthcare provider. Healthcare professionals should consult the FDA recall notice for additional information and instructions on returning or disposing of affected product.
The recalled product
- Product
- TOBRAMYCIN (TOBRAMYCIN)
- Brand
- TOBRAMYCIN
- Manufacturer
- Eugia US LLC
- Category
- Drug — Injectable Antibiotic
- Affected units
- 1,160
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #s: 3TB23001
- 3TB23002
- Exp. 04/30/2025.
UPCs (1)
- 0355150470013
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Eugia US LLC
See all →- ModerateEugia lidocaine vial label wrap covers the barcode
FDA (Drugs) · 2026-06-10
- ModerateGentamicin Injection Pediatric Vials Recalled for Failed Stability Tests
FDA (Drugs) · 2025-06-25
- ModerateTirofiban Hydrochloride Injection recalled for out-of-specification test results
FDA (Drugs) · 2025-05-07
- ModerateTirofiban Injection Recalled for Out-of-Specification Test Results
FDA (Drugs) · 2025-05-07
- ModerateTestosterone Cypionate Injection Recalled for Insoluble Crystals
FDA (Drugs) · 2025-04-23
Same hazard · stability failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateVasocaine lidocaine spray recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 1 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 2 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateCiclopirox shampoo recalled after failing impurity specifications at eighteen months
FDA (Drugs) · 2025-12-24